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Introduction
Over the past decade, physiotherapists have been
encouraged to take an evidence-based approach to the
teaching and practice of physiotherapy (eg MacIntyre et al
1999, Research Committee (Victorian Branch) of the
Australian Physiotherapy Association and contributors
1999). Evidence-based practice has been defined by
Sackett et al (2000, p. 246) as “the conscientious, explicit
and judicious use of current best evidence in making
decisions about the care of individual patients”. This
involves “integrating individual clinical expertise with the
best available external clinical evidence from systematic
research”. The best available evidence of the benefits and
harms of therapy is provided by systematic reviews of
randomised controlled trials (Level I) and well-designed
randomised (Level II) or pseudo-randomised (Level III-1)
controlled trials (National Health and Medical Research
Council 2000). Many physiotherapists have only limited
access to this high level evidence (due partly to restricted
access to databases that archive clinical trials and reviews
or even an awareness of these databases), which has led to
the belief that there is little evidence about the effects of
physiotherapy interventions (Bithell 2000).
The Physiotherapy Evidence Database (PEDro) was
launched in October 1999 to support an evidence-based
approach to the teaching and practice of physiotherapy
(Sherrington et al 2000). It is a free, Internet-based
resource (http://ptwww.cchs.usyd.edu.au/pedro) developed
and maintained by the Centre for Evidence-Based
Physiotherapy. PEDro contains bibliographic details and
author abstracts of systematic reviews and randomised
controlled trials in physiotherapy. 
To be included on PEDro, randomised controlled trials
must fulfil the following criteria:
• the trial compares at least two interventions (ie at
least one intervention compared with a control or
sham, or a comparison of two or more interventions);
• at least one of the interventions is currently part of
physiotherapy practice, or could become part of
physiotherapy practice;
• the interventions are applied to human subjects who
are representative of those to whom the intervention
might be applied in the course of physiotherapy
practice (ie people with or at risk of developing a
health condition or disability);
• there is random allocation or intended-to-be-random
allocation of subjects to interventions; and
• the trial is published as a full paper in a peer-reviewed
journal.
The second criterion has been interpreted broadly in order
to include the range of treatments that may be used by
physiotherapists internationally. Systematic reviews are
included on PEDro if they are published in a peer reviewed
journal, contain a methods section, and review at least one
trial that satisfies the above criteria.
To assist users of PEDro to interpret the results of research,
randomised controlled trials on the database are rated for
methodological quality by trained PEDro staff or volunteer
physiotherapists (all raters complete a training package and
pass a rating accuracy test) using the PEDro scale (see
Appendix 1). This scale is based on the Delphi list
developed by Verhagen et al (1998), a nine-item list
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established by expert consensus (items: eligibility criteria
specified, subjects randomly allocated to groups, concealed
allocation, groups similar at baseline, blinding of subjects,
therapists and assessors, intention-to-treat analysis, point
measures and measures of variability reported). Two
additional items not on the Delphi list have been included
in the PEDro scale (ie outcome measures obtained from
more than 85% of subjects and reporting of results of
between-group statistical comparisons). Four PEDro scale
items have been validated empirically in the medical
literature: randomisation, concealed allocation, blinding,
and adequacy of follow-up (Moher et al 1999). The other
items have face validity but are yet to be empirically
validated. The PEDro scale has been shown to have
acceptable inter-rater reliability (Moseley et al 1999).
Observed agreement for individual PEDro items ranged
from 70% (groups similar at baseline) to 96% (blinding of
therapists), and the intraclass correlation coefficient for the
total PEDro score (ie the score derived from adding all
PEDro scale items except the specification of eligibility
criteria) was 0.54. To increase the accuracy of quality
ratings on the PEDro database, each trial is independently
rated by two reviewers, with a third rater arbitrating on
items where consensus cannot be reached.
The extent of the external evidence relevant to neurological
physiotherapy archived on PEDro has recently been
surveyed (Moseley et al 2000). There were 238 randomised
controlled trials (54% were categorised as being of
moderate to high quality, rating five or more out of 10 on
the PEDro scale) and 27 systematic reviews relevant to
neurological physiotherapy. However, the quantity and
quality of the external evidence on therapy relevant to other
subdisciplines of physiotherapy or physiotherapy in general
has not been surveyed. Information on the quantity and
quality of the external evidence on therapy is important to
the physiotherapy profession for a number of reasons. This
information can assist the profession in identifying areas of
practice that have not been well evaluated. Most
importantly, this information could guide the profession in
deciding what services should be part of contemporary
physiotherapy practice. An evidence-based practice
perspective would suggest that the profession should
discontinue using treatments that are clearly ineffective and
should consider take-up of new treatments when there is
evidence that they are effective.
This survey aims to describe the quality and quantity of
randomised controlled trials and the quantity of systematic
reviews indexed on PEDro. As PEDro probably is the most
complete database of trials and reviews in physiotherapy,
this survey will provide some insights into the scope of
evidence that can be used to guide decisions about the
effects of therapy. The PEDro database is unique in that it
provides a measure of the quality of the randomised
controlled trials it indexes. This permits statements to be
made about the quality of randomised controlled trials in
physiotherapy.
Method
Data were extracted from PEDro on April 17, 2001. The
authors, title, source, year of publication, publication type
(randomised controlled trial or systematic review) and
quality scores for the records were analysed. Three
analyses were performed. The first focused on the amount
of external evidence available each year. Cumulative totals
of randomised controlled trials and systematic reviews
were calculated. The relationship between the quantity of
reviews and trials and the year of publication was described
using least-squares non-linear curve fitting.
Australian Journal of Physiotherapy 2002  Vol. 4844
Moseley et al: Evidence for physiotherapy practice: A survey of the Physiotherapy Evidence Database (PEDro)
2500
2000
1500
1000
500
0C
um
u
la
tiv
e
 n
u
m
be
r o
f r
ec
or
ds
19
55
19
60
19
65
19
70
19
75
19
80
19
85
19
90
19
95
20
00
Year
Randomised controlled trials
Systematic reviews
Figure 1. Cumulative number of randomised controlled
trials and systematic reviews in physiotherapy by year.
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Figure 2. Frequency distribution of the total PEDro score
for the 2,297 randomised controlled trials with quality
ratings.
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The second analysis investigated the methodological
quality of the randomised controlled trials. The analysis of
methodological quality was performed on the sub-set of
trials that had been quality rated using the PEDro scale (the
remaining trials had bibliographic information entered on
the PEDro database but had not yet been rated). The mean
and standard deviation of the total PEDro score (ie the
score derived by adding all scale items except for Item 1,
the specification of eligibility criteria) for five-year epochs
and the frequency distribution of the total PEDro score for
all rated trials were calculated. In addition, the percentage
of trials satisfying each of the items on the PEDro scale
was determined.
The last analysis examined the evidence available for each
subdiscipline of physiotherapy. All PEDro records were
coded for up to three areas of physiotherapy
(cardiothoracics, continence and women’s health,
ergonomics and occupational health, gerontology,
musculoskeletal, neurology, orthopaedics, paediatrics, and
sports – see Appendix 2). The number of randomised
controlled trials and systematic reviews were calculated for
each area of physiotherapy.
Results
There were 2,708 records indexed on PEDro. Of these,
2,376 were randomised controlled trials and 332 were
systematic reviews (that is, one systematic review for every
7.2 trials)(a). Most records (93%) were in English. The first
archived trials in physiotherapy were published in 1955(a),
about seven years after the first modern randomised
controlled trial in medicine (Medical Research Council
1948). These trials investigated manipulation for low back
pain (Coyer and Curwen 1955) and wax baths for
rheumatoid arthritis (Harris and Millard 1955). The
number of randomised controlled trials has increased
rapidly and approximately exponentially since then (Figure
1). An exponential growth curve fits the data well (number
of trials = e 0.18 x years since 1955; r2 = 0.94). An average of 155
trials were published each year from 1995 to 1999.
The first archived systematic review relevant to
physiotherapy was published in 1982 and investigated the
effects of weight loss treatments (including exercise) on
hypertension (Hovell 1982). Since then, there has been an
exponential increase in the number of systematic reviews,
with 59 published in 1999. Again, an exponential growth
curve fits the data very well (number of reviews = 
e 0.33 x years since 1982; r2 = 0.99).
Of the 2,376 randomised controlled trials archived on
PEDro at April 17, 2001, 2,297 (or 97%) had been rated for
methodological quality at least once and 1,235 (52%) had
ratings confirmed by a second or third rater (the remaining
79 trials had bibliographic information entered on the
PEDro database but had not yet been rated). Trial quality
ranged from 0/10 to 10/10, with most rating 4 or 5 (Figure
2). Fifty-two per cent of trials were nominally of moderate
to high quality, rating 5 or more on the PEDro scale.
The quality of randomised controlled trials in
physiotherapy has increased gradually since 1955 (Figure
3). The mean total PEDro score has increased from 2.8 for
trials published between 1955 and 1959, to 5.0 for trials
published between 1995 and 1999 (the mean for trials
published in 2000 or 2001 is 5.7). 
The percentage of rated randomised controlled trials that
satisfy each item on the PEDro scale is illustrated in Figure
4. Most trials (94%) fulfilled the randomisation item of the
PEDro scale (ie subjects were randomly allocated to
experimental conditions). This is not surprising given that
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Figure 3. Mean and standard deviation of the total PEDro
score of rated randomised controlled trials in physiotherapy
for each 5-year period since 1955 (plus the trials published
in 2000 or 2001). The number of trials for each epoch is
indicated at the end of each bar.
Figure 4. Percentage of rated randomised controlled trials
that satisfied each item of the PEDro scale.
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trials are only eligible for PEDro if they use a randomised
or intended-to-be-randomised method of allocation. Other
high-rating PEDro scale items were the reporting of
between-group statistical comparisons (89% of trials) and
the provision of point estimates and measures of variability
(82% of trials). The trials showed lower compliance for
three features that have been shown to predict bias in
clinical trials (concealed allocation to groups, blinding, and
adequacy of follow-up; Moher et al 1999). Only 16%
clearly used concealed allocation and 59% of trials clearly
had a dropout rate of less than 15%. The prevalence of
blinding was low. Very few trials used blinded therapists
(5% of trials) or subjects (9% of trials), but about one-third
(34% of trials) blinded the assessors. Only 12% of trials
reported using an intention-to-treat analysis.
The systematic reviews and randomised controlled trials
covered most areas of physiotherapy (Figure 5). Note that
the columns in this figure do not tally with the total number
of records on PEDro because trials and reviews can be
relevant to more than one area of physiotherapy. Trials and
reviews can be coded for up to three areas of physiotherapy.
The ‘other’ category in Figure 5 is used when the record
cannot be classified using the subdiscipline definitions (see
Appendix 2). The largest number of trials and reviews
(39% of trials and 36% of reviews) were in the area of
musculoskeletal physiotherapy. 
Discussion
Contrary to popular belief, there is a significant body of
evidence to guide the practice and teaching of
physiotherapy. Much of this evidence is archived on PEDro
which, in April 2001, contained 2,376 randomised
controlled trials and 332 systematic reviews. This may be
an underestimate of the amount of evidence, although it is
difficult to estimate how many trials and reviews are not on
the PEDro database. Trials published in languages other
than English are probably significantly under-represented
because the majority of PEDro staff and volunteers are
fluent in English only.
There were randomised controlled trials and systematic
reviews relevant to all subdisciplines of physiotherapy. Not
surprisingly, the largest number of trials and reviews were
in the area of musculoskeletal physiotherapy. The evidence
for neurological physiotherapy, which had been surveyed
previously (Moseley et al 2000), ranked fourth. Paediatrics
and ergonomics were the areas of physiotherapy with the
smallest number of trials and reviews. These areas could be
priority areas for future research funding.
While the PEDro database contains 332 systematic
reviews, it is likely that many clinical questions in
physiotherapy are yet to be addressed by these reviews. It is
unclear from this survey whether this is primarily due to a
lack of randomised controlled trials in particular areas or a
lack of systematic reviews summarising completed trials.
A substantial number of the randomised controlled trials in
physiotherapy are nominally of moderate to high quality.
Fifty-two per cent of trials were of moderate to high
quality, rating 5 or more on the PEDro scale, and the mean
PEDro score has been increasing since the first randomised
controlled trial in physiotherapy was published in 1955.
This means there is a significant amount of Level II and
Level III-1 evidence that is likely to be valid and to have
sufficient statistical information to make the results
interpretable. Such information can guide the practice and
teaching of physiotherapy.
The methodological quality of randomised controlled trials
archived on PEDro was assessed using the PEDro scale.
While the PEDro scale has adequate reliability (Moseley et
al 1999), it has not been empirically validated. However,
the PEDro scale does include the four features known to
minimise bias in clinical trials (ie randomisation, concealed
allocation, blinding, and minimising the dropout rate;
Moher et al 1999), and the remaining items have face
validity. Several of the items that have not been empirically
validated were nominated by a panel of experts as being
indicative of methodological quality (Verhagen et al 1998).
The total PEDro score may be used by physiotherapists as
a guide to differentiate trials that are more likely to be valid
and contain sufficient statistical information to be
interpretable from those that are not.
The quality of the conduct and reporting of future trials in
physiotherapy could be improved. Only a small proportion
of physiotherapy trials reported three features that have
been shown to predict bias in clinical trials (concealed
allocation to groups, blinding and adequate follow-up).
While concealed allocation is theoretically possible in all
randomised trials, only 16% of physiotherapy trials clearly
report using concealed allocation. Similarly, blinding of the
assessors of outcomes should almost always be possible,
but was only evident in 34% of the trials archived on
PEDro. Blinding of therapists may not be possible in many
Australian Journal of Physiotherapy 2002  Vol. 4846
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Figure 5. Number of randomised controlled trials and
systematic reviews available in each area of physiotherapy
(columns do not tally with the total number of trials on
PEDro because trials and reviews can be coded for up to
three areas of physiotherapy).
trials that evaluate exercise, manual therapy and education,
but it should be possible in trials that evaluate
electrotherapies such as laser and ultrasound.
While it is desirable to blind subjects, this is difficult for
many physiotherapy interventions. Two recent papers have
shown some interesting approaches to this difficult
problem. Streitberger and Kleinhenz (1998) reported a
protocol for sham acupuncture that patients could not
distinguish from real acupuncture. The protocol uses a
‘sham’ needle that retracts into the handle when it touches
the skin. The patients feel a pricking sensation and see the
shortening of the needle as would occur with real
acupuncture. Van Tulder et al (2000) have advocated that
where blinding is not feasible, the use of a sham treatment
that was demonstrated to be equally credible and
acceptable to the patient should be regarded as passing the
criterion for subject blinding if the trial formally assesses
the equal credibility of treatment. In contrast, Vickers and
de Craen (2000) have argued that sham or placebo-
controlled trials sacrifice external validity for internal
validity and do not inform clinical decision making as well
as trials in which the control group is not administered a
sham therapy.
Like randomised controlled trials, the quality of systematic
reviews vary. While the methodological quality of
systematic reviews have not been evaluated on the PEDro
database, physiotherapists could use a number of resources
to identify reviews that are likely to be valid. First, the
quality of Cochrane systematic reviews is likely to be high
as they are performed according to stringent guidelines.
Second, the Database of Abstracts of Reviews of
Effectiveness (DARE; University of York 2000) provides
structured abstracts and quality assessments for many of
the systematic reviews archived on PEDro. About 50% of
the systematic reviews relevant to neurological
physiotherapy have structured abstracts on DARE
(Moseley et al 2000). Third, readers can assess individual
systematic reviews for the presence of features known to
introduce bias. The filters suggested by the National Health
and Medical Research Council (2000) include the
adequacy of the search strategy used, the use of appropriate
inclusion criteria that were applied in an unbiased way,
quality assessment of included studies, the appropriate
summarising of the characteristics and results of the
individual studies, the use of appropriate methods for
pooling the data, and exploration of sources of
heterogeneity.
The amount of external evidence about therapy relevant to
physiotherapy is significant and growing at an exponential
rate. This poses a challenge to even the most dedicated
physiotherapist who, based on current publication rates,
would have to read approximately 155 trials and 59 reviews
each year to keep abreast of the physiotherapy literature.
Some solutions to this problem of information overload are
to restrict reading to the area of current practice, read only
high quality randomised controlled trials and systematic
reviews, and make use of distilled literature such as the
Critically Appraised Papers section of this journal.
Conclusion
This survey of the Physiotherapy Evidence Database
(PEDro) revealed a significant body of high level external
evidence (both randomised controlled trials and systematic
reviews) that can be used to support decision-making about
therapy for all subdisciplines of physiotherapy. The amount
of evidence is expanding at an exponential rate and the
quality of trials is increasing. While there is a relatively
large amount of high quality evidence available, there still
remains scope for improvements in the quality of the
conduct and reporting of clinical trials.
Footnote  (a) Since this paper was accepted for publication,
the PEDro database has continued to expand. In January
2002 PEDro contained 2,712 randomised controlled trials
and 411 systematic reviews. We have also identified some
trials that were published before the first trials in
physiotherapy cited in this paper. Two trials were published
before 1955, both in the area of cardiothoracic
physiotherapy. They are Palmer  and Sellick (1952) and
Palmer and Sellick (1953).
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Appendix 1: Criteria for the PEDro scale
1 eligibility criteria were specified
2 subjects were randomly allocated to groups (in a
crossover study, subjects were randomly allocated an
order in which treatments were received)
3 allocation was concealed
4 the groups were similar at baseline regarding the
most important prognostic indicators
5 there was blinding of all subjects
6 there was blinding of all therapists who administered
the therapy
7 there was blinding of all assessors who measured at
least one key outcome
8 measures of at least one key outcome were obtained
from more than 85% of the subjects initially allocated
to groups
9 all subjects for whom outcome measures were
available received the treatment or control condition
as allocated or, where this was not the case, data for
at least one key outcome was analysed by “intention
to treat”
10 the results of between-group statistical comparisons
are reported for at least one key outcome
11 the study provides both point measures and measures
of variability for at least one key outcome
Notes on administration of the PEDro scale:
All criteria  Points are only awarded when a criterion is
clearly satisfied. If on a literal reading of the trial report it
is possible that a criterion was not satisfied, a point should
not be awarded for that criterion.
Criterion 1 This criterion is satisfied if the report describes
the source of subjects and a list of criteria used to
determine who was eligible to participate in the study.
Criterion 2 A study is considered to have used random
allocation if the report states that allocation was random.
The precise method of randomisation need not be
specified. Procedures such as coin-tossing and dice-rolling
should be considered random. Quasi-randomisation
allocation procedures such as allocation by hospital record
number or birth date, or alternation, do not satisfy this
criterion. 
Criterion 3 Concealed allocation means that the person
who determined if a subject was eligible for inclusion in
the trial was unaware, when this decision was made, of
which group the subject would be allocated to. A point is
awarded for this criteria, even if it is not stated that
allocation was concealed, when the report states that
allocation was by sealed opaque envelopes or that
allocation involved contacting the holder of the allocation
schedule who was “off-site”.
Criterion 4 At a minimum, in studies of therapeutic
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interventions, the report must describe at least one measure
of the severity of the condition being treated and at least
one (different) key outcome measure at baseline. The rater
must be satisfied that the groups’ outcomes would not be
expected to differ, on the basis of baseline differences in
prognostic variables alone, by a clinically significant
amount. This criterion is satisfied even if only baseline data
of study completers are presented.
Criteria 4, 7-11 Key outcomes are those outcomes which
provide the primary measure of the effectiveness (or lack of
effectiveness) of the therapy. In most studies, more than
one variable is used as an outcome measure.
Criterion 5-7 Blinding means the person in question
(subject, therapist or assessor) did not know which group
the subject had been allocated to. In addition, subjects and
therapists are only considered to be “blind” if it could be
expected that they would have been unable to distinguish
between the treatments applied to different groups. In trials
in which key outcomes are self-reported (eg visual
analogue scale, pain diary), the assessor is considered to be
blind if the subject was blind.
Criterion 8 This criterion is only satisfied if the report
explicitly states both the number of subjects initially
allocated to groups and the number of subjects from whom
key outcome measures were obtained. In trials in which
outcomes are measured at several points in time, a key
outcome must have been measured in more than 85% of
subjects at one of those points in time.
Criterion 9 An intention to treat analysis means that,
where subjects did not receive treatment (or the control
condition) as allocated, and where measures of outcomes
were available, the analysis was performed as if subjects
received the treatment (or control condition) they were
allocated to. This criterion is satisfied, even if there is no
mention of analysis by intention to treat, if the report
explicitly states that all subjects received treatment or
control conditions as allocated.
Criterion 10 A between-group statistical comparison
involves statistical comparison of one group with another.
Depending on the design of the study, this may involve
comparison of two or more treatments, or comparison of
treatment with a control condition. The analysis may be a
simple comparison of outcomes measured after the
treatment was administered, or a comparison of the change
in one group with the change in another (when a factorial
analysis of variance has been used to analyse the data, the
latter is often reported as a group × time interaction). The
comparison may be in the form hypothesis testing (which
provides a p value, describing the probability that the
groups differed only by chance) or in the form of an
estimate (for example, the mean or median difference, or a
difference in proportions, or number needed to treat, or a
relative risk or hazard ratio) and its confidence interval.
Criterion 11 A point measure is a measure of the size of
the treatment effect. The treatment effect may be described
as a difference in group outcomes, or as the outcome in
(each of) all groups. Measures of variability include
standard deviations, standard errors, confidence intervals,
interquartile ranges (or other quantile ranges) and ranges.
Point measures and/or measures of variability may be
provided graphically (for example, SDs may be given as
error bars in a Figure) as long as it is clear what is being
graphed (for example, as long as it is clear whether error
bars represent SDs or SEs). Where outcomes are
categorical, this criterion is considered to have been met if
the number of subjects in each category is given for each
group.
Appendix 2: PEDro definitions for each
sub-discipline of physiotherapy
Cardiothoracics includes, but is not restricted to, papers
evaluating acute and rehabilitation cardiothoracic
interventions or fitness training on those with conditions
affecting the cardiothoracic system. This subdiscipline
does not include studies of general fitness training among
patient populations. Studies of general fitness training for
healthy populations are not indexed on PEDro
Continence and women’s health includes, but is not
restricted to, male and female incontinence and pre- and
post-natal interventions for the mother
Ergonomics and occupational health includes, but is not
restricted to, interventions based at workplaces or on
workers for work-related conditions
Gerontology includes papers where the average age of the
study sample is over 60, and papers on conditions which
commonly affect older people (eg arthritis)
Musculoskeletal includes, but is not restricted to, low back
pain, rheumatoid disease, entrapment syndromes and
neuralgia
Neurology includes, but is not restricted to, lesions of the
central and peripheral nervous systems excluding those
whose primary presentation is pain or paraesthesia such as
carpal tunnel syndrome, neuralgia or sciatica
Orthopaedics includes only fractures and intervention
before or after orthopaedic surgery (eg knee replacements,
ligament repairs)
Paediatrics includes papers where the average age of the
study sample is under 16, and papers on conditions which
commonly affect children (eg cystic fibrosis)
Sports includes papers which specifically mention sports
injuries as well as conditions which commonly affect sports
people (eg ligament repairs)
If the area for a particular paper does not fit under any of
the above categories, the code “no appropriate value in this
field” is used.
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